Clinical aspects of X-linked hypohidrotic ectodermal dysplasia.

A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet (2000) 2.48

Modeling recent human evolution in mice by expression of a selected EDAR variant. Cell (2013) 2.17

Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest (2002) 1.83

The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases. Orphanet J Rare Dis (2011) 1.72

Identification of a new splice form of the EDA1 gene permits detection of nearly all X-linked hypohidrotic ectodermal dysplasia mutations. Am J Hum Genet (1998) 1.51

X-linked hypohidrotic ectodermal dysplasia: localization within the region Xq11-21.1 by linkage analysis and implications for carrier detection and prenatal diagnosis. Am J Hum Genet (1988) 1.21

Significant correction of disease after postnatal administration of recombinant ectodysplasin A in canine X-linked ectodermal dysplasia. Am J Hum Genet (2007) 1.20

Twenty-four cases of the EEC syndrome: clinical presentation and management. J Med Genet (1995) 1.20

Mutations within a furin consensus sequence block proteolytic release of ectodysplasin-A and cause X-linked hypohidrotic ectodermal dysplasia. Proc Natl Acad Sci U S A (2001) 1.15

Definitive evidence for an autosomal recessive form of hypohidrotic ectodermal dysplasia clinically indistinguishable from the more common X-linked disorder. Am J Hum Genet (1997) 1.13

High-resolution mapping of the X-linked hypohidrotic ectodermal dysplasia (EDA) locus. Am J Hum Genet (1992) 1.07

Mutation identification in a canine model of X-linked ectodermal dysplasia. Mamm Genome (2005) 1.03

Enhanced Edar signalling has pleiotropic effects on craniofacial and cutaneous glands. PLoS One (2009) 1.02

Chronic idiopathic anhydrosis--a rare cause of heat stroke. Postgrad Med J (1992) 1.00

Ectodysplasin regulates hormone-independent mammary ductal morphogenesis via NF-κB. Proc Natl Acad Sci U S A (2012) 0.99

Ectodermal dysplasia. Arch Dis Child (1994) 0.99

Salivary gland branching morphogenesis: a quantitative systems analysis of the Eda/Edar/NFkappaB paradigm. BMC Dev Biol (2009) 0.99

Neonatal treatment with recombinant ectodysplasin prevents respiratory disease in dogs with X-linked ectodermal dysplasia. Am J Med Genet A (2009) 0.96

Detection of a molecular deletion at the DXS732 locus in a patient with X-linked hypohidrotic ectodermal dysplasia (EDA), with the identification of a unique junctional fragment. Am J Hum Genet (1993) 0.95

Scarcity of mutations detected in families with X linked hypohidrotic ectodermal dysplasia: diagnostic implications. J Med Genet (1998) 0.89

Early respiratory and ocular involvement in X-linked hypohidrotic ectodermal dysplasia. Eur J Pediatr (2013) 0.89

Detection of de novo mutations and analysis of their origin in families with X linked hypohidrotic ectodermal dysplasia. J Med Genet (1994) 0.89

Molecular basis of hypohidrotic ectodermal dysplasia: an update. J Appl Genet (2015) 0.88

Sweat testing to identify female carriers of X linked hypohidrotic ectodermal dysplasia. J Med Genet (1991) 0.87

Frequent respiratory tract infections in the canine model of X-linked ectodermal dysplasia are not caused by an immune deficiency. Vet Immunol Immunopathol (2005) 0.87

Recognition and reanalysis of a cell line from a manifesting female with X linked hypohidrotic ectodermal dysplasia and an X; autosome balanced translocation. J Med Genet (1988) 0.84

Autosomal recessive anhidrotic ectodermal dysplasia in a large Moroccan family. J Med Genet (1998) 0.84

NF-κB Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria. Mediterr J Hematol Infect Dis (2015) 0.83

Autosomal recessive anhidrotic ectodermal dysplasia: a rare entity. Indian J Dermatol (2014) 0.83

Reduced epidermal growth factor receptor expression in hypohidrotic ectodermal dysplasia and Tabby mice. J Clin Invest (1996) 0.82

On the genetics of hypodontia and microdontia: synergism or allelism of major genes in a family with six affected members. J Med Genet (1996) 0.82

Orofacial features of hypohidrotic ectodermal dysplasia. Head Neck Pathol (2012) 0.81

Foxc1 Ablated Mice Are Anhidrotic and Recapitulate Features of Human Miliaria Sweat Retention Disorder. J Invest Dermatol (2016) 0.81

Consider further differential diagnoses. Dtsch Arztebl Int (2014) 0.80

Pharmacological stimulation of Edar signaling in the adult enhances sebaceous gland size and function. J Invest Dermatol (2014) 0.79

Possible genetic heterogeneity in X linked hypohidrotic ectodermal dysplasia. J Med Genet (1990) 0.78

Characterization of X-linked hypohidrotic ectodermal dysplasia (XL-HED) hair and sweat gland phenotypes using phototrichogram analysis and live confocal imaging. Am J Med Genet A (2013) 0.78

Ectodysplasin/NF-κB Promotes Mammary Cell Fate via Wnt/β-catenin Pathway. PLoS Genet (2015) 0.78

Mutational spectrum in 101 patients with hypohidrotic ectodermal dysplasia and breakpoint mapping in independent cases of rare genomic rearrangements. J Hum Genet (2016) 0.77

Hypohidrotic ectodermal dysplasia, central nervous system malformation, and distinct facial features: confirmation of a distinct entity? J Med Genet (1993) 0.77

Anticipated stigma and blameless guilt: Mothers' evaluation of life with the sex-linked disorder, hypohidrotic ectodermal dysplasia (XHED). Soc Sci Med (2016) 0.76

Christ-Siemens-Touraine syndrome with palmoplantar keratoderma: A rare association. Indian Dermatol Online J (2016) 0.75

A Novel Splicesite Mutation in the EDAR Gene Causes Severe Autosomal Recessive Hypohydrotic (Anhidrotic) Ectodermal Dysplasia in an Iranian Family. Int J Mol Cell Med (2016) 0.75

Christ-siemens-touraine syndrome: case report of 2 brothers. J Clin Diagn Res (2014) 0.75

Familial ectodermal dysplasia: a peers' agony. BMJ Case Rep (2013) 0.75

Prevalence of atopic disorders and immunodeficiency in patients with ectodermal dysplasia syndromes. Ann Allergy Asthma Immunol (2012) 0.75

Hypohidrotic ectodermal dysplasia and immunodeficiency with coincident NEMO and EDA mutations. Front Immunol (2011) 0.75

A novel treatment strategy for eyebrow transplantation in an ectodermal dysplasia patient. J Res Med Sci (2012) 0.75

Karyotyping, dermatoglyphic, and sweat pore analysis of five families affected with ectodermal dysplasia. J Oral Maxillofac Pathol (2012) 0.75

Effect of an EDA-A1 gene mutant on the proliferation and cell cycle distribution of cultured human umbilical vein endothelial cells. Exp Ther Med (2015) 0.75

Ectodysplasin target gene Fgf20 regulates mammary bud growth and ductal invasion and branching during puberty. Sci Rep (2017) 0.75

Hypohidrotic ectodermal dysplasia with hypothyroidism. J Pediatr (1981) 1.61

Expression of X-linked hypohidrotic ectodermal dysplasia in six males and in their mothers. Clin Genet (1985) 1.35

X-linked hypohidrotic ectodermal dysplasia: DNA probe linkage analysis and gene localization. Hum Genet (1987) 1.31

An automated immunoradiometric assay for human thyrotropin. Clin Chem (1984) 1.23

Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome. Q J Med (1986) 1.12

Anhidrotic ectodermal dysplasia presenting as a pyrexia of undertermined origin in the neonatal period. Postgrad Med J (1968) 1.10

Manifestation of the lines of Blaschko in women heterozygous for X-linked hypohidrotic ectodermal dysplasia. Clin Genet (1985) 1.09

Cellular immunodeficiency in anhidrotic ectodermal dysplasia. Acta Derm Venereol (1976) 1.07

Hypodontia, ectodermal dysplasia and sweat pore count. Br Dent J (1985) 1.06

Cytidine 5'-diphosphate reductase and thymidine kinase activities in phytohemagglutinin-stimulated lymphocytes of normal subjects of various ages and patients with immunodeficiency. Pediatr Res (1984) 1.00

A study of cell mediated and humoral immunity in haemophilia and related disorders. Br J Haematol (1985) 0.97

Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature (1982) 11.57

Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Res (1983) 8.92

Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature (1992) 8.85

Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet (1993) 5.70

Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg (1970) 5.62

Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain (1988) 4.69

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet (1989) 4.42

Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study. Lancet (2000) 4.22

Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature (1988) 3.57

Nationalism and patriotism: national identification and out-group rejection. Br J Soc Psychol (2001) 3.33

Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature (1995) 3.22

Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning. Nature (1994) 3.19

Prevalence of urethral Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic, sexually active adolescent boys. J Infect Dis (1987) 3.02

Trauma care regionalization: a process-outcome evaluation. J Trauma (1999) 3.02

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A (1997) 3.00

A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord (2005) 2.96

Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet (1996) 2.88

Reaction of endotoxin and surfactants. I. Physical and biological properties of endotoxin treated with sodium deoxycholate. J Bacteriol (1966) 2.86

Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82

Evaluation of readability and accuracy of information leaflets in general practice for patients with asthma. BMJ (1998) 2.75

The prevention of Huntington's chorea. The Milroy lecture 1985. J R Coll Physicians Lond (1986) 2.74

Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis (1984) 2.67

Genetic risks for children of women with myotonic dystrophy. Am J Hum Genet (1991) 2.65

The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med (1995) 2.56

Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet (1994) 2.53

Evidence for a polar ethane cloud on Titan. Science (2006) 2.50

The evolution of Titan's mid-latitude clouds. Science (2005) 2.46

The use of linked DNA polymorphisms for genotype prediction in families with Duchenne muscular dystrophy. J Med Genet (1983) 2.45

Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet (1997) 2.44

Hand-held thoracic sonography for detecting post-traumatic pneumothoraces: the Extended Focused Assessment with Sonography for Trauma (EFAST). J Trauma (2004) 2.44

Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet (1993) 2.42

Human N-ras: cDNA cloning and gene structure. Nucleic Acids Res (1985) 2.41

Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab (1998) 2.41

Early-onset dystrophia myotonica. Evidence supporting a maternal environmental factor. Lancet (1972) 2.40

The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature (1987) 2.38

Unstable DNA sequence in myotonic dystrophy. Lancet (1992) 2.36

An evaluation of the Gaspak system in the culture of anaerobic bacteria. J Appl Bacteriol (1972) 2.33

Huntington's Chorea in South Wales. A genetic and epidemiological study. Clin Genet (1981) 2.31

Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav (2001) 2.20

Weight gain in infancy and cancer of the ovary. Lancet (1995) 2.20

Studies of a DNA marker (G8) genetically linked to Huntington disease in British families. Hum Genet (1986) 2.18

Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Res (2000) 2.17

Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome. J Med Genet (1983) 2.16

Molecular analysis and clinical correlations of the Huntington's disease mutation. Lancet (1993) 2.15

Intramuscular rocuronium in infants and children. Dose-ranging and tracheal intubating conditions. Anesthesiology (1996) 2.14

Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol (2007) 2.12

Cause of death in rheumatoid arthritis. Br J Rheumatol (1984) 2.12

Exclusion testing for Huntington's disease in pregnancy with a closely linked DNA marker. Lancet (1987) 2.09

Adoption and genetic prediction for Huntington's disease. Lancet (1988) 2.09

Insuring Latinos against the costs of illness. JAMA (1993) 2.09

Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet (1987) 2.08

Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial. JAMA (2001) 2.06

Polycystic kidney disease re-evaluated: a population-based study. Q J Med (1991) 2.05

Linkage disequilibrium in Huntington's disease: an improved localisation for the gene. J Med Genet (1989) 2.05

Congenital myotonic dystrophy in Britain. I. Clinical aspects. Arch Dis Child (1975) 2.04

A pharmacodynamic explanation for the rapid onset/offset of rapacuronium bromide. Anesthesiology (1999) 2.03

Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD) Hum Mol Genet (1995) 2.02

Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line. J Biol Chem (1996) 2.01

Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst (1985) 2.00

Problems in genetic prediction for Huntington's disease. Lancet (1989) 2.00

Cardiac disease in myotonic dystrophy. Cardiovasc Res (1997) 1.98

New cosmid vectors developed for eukaryotic DNA cloning. Gene (1984) 1.97

Acute infectious epiglottitis in adults. Ann Intern Med (1969) 1.97

Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositol. Mol Immunol (1989) 1.94

Training in international animal health. Vet Rec (2001) 1.93

EXPERIENCES WITH SODIUM AMYTAL AS A GENERAL ANAESTHETIC. Ann Surg (1930) 1.93

George Otto Gey. (1899-1970). The HeLa cell and a reappraisal of its origin. Obstet Gynecol (1971) 1.93

A death-domain-containing receptor that mediates apoptosis. Nature (1996) 1.92

Risk of macular degeneration in users of statins: cross sectional study. BMJ (2001) 1.92

A new DNA marker tightly linked to the fragile X locus (FRAXA). Science (1989) 1.88

An evaluated programme of rheumatology training for general practitioners. Br J Rheumatol (1986) 1.88

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling. J Med Genet (1989) 1.87

Huntington's chorea. The basis for long-term prevention. Lancet (1979) 1.87

Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ (1992) 1.86

Hemoglobin desaturation after succinylcholine-induced apnea: a study of the recovery of spontaneous ventilation in healthy volunteers. Anesthesiology (2001) 1.84

Studies on the mode of action of diphtheria toxin. VII. Toxin-stimulated hydrolysis of nicotinamide adenine dinucleotide in mammalian cell extracts. J Exp Med (1969) 1.83

Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet (1996) 1.83

Genetic linkage confirmed between the locus for myotonic dystrophy and the ABH-secretion and Lutheran blood group loci. Am J Hum Genet (1972) 1.82

Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. Hum Mol Genet (2001) 1.81

The recovery of anaerobic bacteria from swabs. J Hyg (Lond) (1974) 1.80

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. Oncogene (1999) 1.80

Factors influencing age at onset and duration of survival in Huntington's chorea. Ann Hum Genet (1981) 1.79

Screening for Duchenne muscular dystrophy. Arch Dis Child (1989) 1.78

Epigenetics as a mechanism driving polygenic clinical drug resistance. Br J Cancer (2006) 1.77

Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry (1986) 1.74

Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences. Hum Genet (1984) 1.74

Attitudes of mothers to neonatal screening for Duchenne muscular dystrophy. BMJ (1990) 1.72

Congenital myotonic dystrophy in Britain. II. Genetic basis. Arch Dis Child (1975) 1.71

Huntington disease: no evidence for locus heterogeneity. Genomics (1989) 1.70

Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer (1986) 1.70

A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet (2001) 1.69

Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes. Diabet Med (2011) 1.68

Attitudes of subjects at risk and their relatives towards genetic counselling in Huntington's chorea. J Med Genet (1983) 1.67

A scheme for the identification of clinical isolates of Gram-negative anaerobic bacilli by conventional bacteriological tests. J Med Microbiol (1980) 1.67

Homologous alpha satellite sequences on human acrocentric chromosomes with selectivity for chromosomes 13, 14 and 21: implications for recombination between nonhomologues and Robertsonian translocations. Nucleic Acids Res (1988) 1.67

A clinical and genetic study of Hunter's syndrome. 2. Differences between the mild and severe forms. J Med Genet (1982) 1.66

Decline in the predicted incidence of Huntington's chorea associated with systematic genetic counselling and family support. Lancet (1981) 1.64

Detection of linkage disequilibrium between the myotonic dystrophy locus and a new polymorphic DNA marker. Am J Hum Genet (1991) 1.64

Evidence from family studies that the gene causing Huntington disease is telomeric to D4S95 and D4S90. Am J Hum Genet (1989) 1.64

Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res (1996) 1.63